Updates in Breast Cancer from San Antonio


 

SABCS 2019 Highlights: New Data Demonstrate the Potential of Trastuzumab Deruxtecan Becoming the New SoC in HER2+ Metastatic Breast Cancer

0 views
February 10, 2020
Comments 0
Login to view comments. Click here to Login